Pathogenesis and treatment of skin lesions caused by sulfur mustard

Cutaneous and Ocular Toxicology

Volumn 31, Issue 3, 2012, Pages 241-249

  Poursaleh, Zohreh ^a   Ghanei, Mostafa ^a   Babamahmoodi, Farhang ^b   Izadi, Morteza ^a   Harandi, Ali Amini ^a   Emadi, Seyed Emad ^c   Taghavi, Nez'Hat O Sadat ^d   Sayad Nouri, Seyede Somaye ^e   Emadi, Seyed Naser ^a,b,e,f  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Iran Research and Medical Center   (Iran)

^d SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Pathogenesis; Review; Skin; Sulfur mustard; Toxicity; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BACITRACIN ZINC; CALAMINE; CAPSAICIN; CARBAMAZEPINE; CETIRIZINE; CORTICOSTEROID; DOXEPIN; DOXYCYCLINE; EMOLLIENT AGENT; HYDROXYZINE; INDOMETACIN; IODINE; LANOLIN ALCOHOL; LIDOCAINE; MAFENIDE ACETATE; MENTHOL; MUSTARD GAS; NICOTINAMIDE; OXYBUPROCAINE; PHENOL; PIMECROLIMUS; POVIDONE IODINE; SELENIUM; SULFADIAZINE SILVER; TACROLIMUS; TRIFLUOPERAZINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; ZINC OXIDE;

APOPTOSIS; BLISTER; CARCINOGENICITY; CELL DEATH; CELL PROLIFERATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DEBRIDEMENT; DRUG EFFICACY; HEAT; HISTOPATHOLOGY; HUMAN; HYDROCOLLOID; HYDROGEL; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; INDUCED HYPOTHERMIA; KERATINOCYTE; LETHAL DOSE; MOISTURE; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL CIRCULATION; PROPHYLAXIS; PROTECTIVE CLOTHING; PRURITUS; REVIEW; SECONDARY INFECTION; SKIN ABSORPTION; SKIN CANCER; SKIN DECONTAMINATION; SKIN DEFECT; SKIN EDEMA; SKIN INFLAMMATION; SKIN PAIN; SKIN SCAR; SKIN TOXICITY; SKIN TRANSPLANTATION; WOUND HEALING; XEROSIS;

CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; ECZEMA; HUMANS; MUSTARD GAS; PRURITUS; SKIN DISEASES; SKIN NEOPLASMS; SKIN PIGMENTATION; WOUND HEALING;

EID: 84865345853     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.636119     Document Type: Review

References (74)

1. Wattana M, Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp Disaster Med 2009;24:19-29; discussion 30.
2. Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK, Casillas RP et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010;114:5-19.
3. Chiesman WE. Lesions due to Vesicants: Diagnosis and Treatment. Br Med J 1944;2:109-112.
4. Firooz A, Sadr B, Davoudi SM, Nassiri-Kashani M, Panahi Y, Dowlati Y. Long-term skin damage due to chemical weapon exposure. Cutan Ocul Toxicol 2011;30:64-68.
5. Davoudi SM, Keshavarz S, Sadr B, Shohrati M, Naghizadeh MM, Farsinejad K et al. Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study. J Eur Acad Dermatol Venereol 2009;23: 940-944.
6. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Amir A, Kadar T. Potential anti-infammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum Exp Toxicol 2002;21:197-203. (Pubitemid 34662046)
7. Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Tiermann H. Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty 2008;8:e32.
8. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005;214:198-209. (Pubitemid 41406260)
9. Renshow B. (1946). Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustard. In: Kirner R, ed. Chemical Warfare Agents, and Related Chemical Problems. Washington, DC: Government printing Ofce, 479-520.
10. Papirmeister B, Gross CL, Meier HL, Petrali JP, Johnson JB. Molecular basis for mustard-induced vesication. Fundam Appl Toxicol 1985;5:S134-S149. (Pubitemid 16134975)
11. Nagy SM, Golumbic C. Te penetration of vesicant vapors into human skin. J Gen Physiol 1946;29:441-469.
12. Marshall Ek, Jr, Lynch V, Smith Hw. On dichlorethylsulfdec (mustard gas)II. Variations in susceptibility of the skin to dichlorethylsulfde. J Pharmacol Exp Ter 1919;12:91-301.
13. Papirmeister B, Gross CL, Petrali JP, Hixson CJ. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice. Cutan Ocul Toxicol 1984;3:371-408.
14. Petrali JP, Oglesby SB, Hamilton TA, Mills KR. Comparative morphology of sulfur mustard efects in the hairless guinea pig and a human skin equivalent. J Submicrosc Cytol Pathol 1993;25:113-118.
15. Hayden PJ, Petrali JP, Stolper G, Hamilton TA, Jackson GR Jr, Wertz PW et al. Microvesicating efects of sulfur mustard on an in vitro human skin model. Toxicol In Vitro 2009;23:1396-1405.
16. Ghanei M, Poursaleh Z, Harandi AA, Emadi SE, Emadi SN. Acute and chronic efects of sulfur mustard on the skin: a comprehensive review. Cutan Ocul Toxicol 2010;29:269-277.
17. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM. Mustard gas toxicity: the acute and chronic pathological efects. J Appl Toxicol 2010;30:627-643.
18. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS. Mustard gas scarring with specifc pigmentary, trophic and vascular charactristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 2008;69:574-576. (Pubitemid 351305014)
19. Emadi SN, Kafashi M, Poursaleh Z, Akhavan-Moghaddam J, Soroush MR, Emadi SE et al. Sulfur mustard-induced poikiloderma: a case report. Cutan Ocul Toxicol 2011;30:170-174.
20. Kan RK, Pleva CM, Hamilton TA, Anderson DR, Petrali JP. Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol Pathol 2003;31:185-190. (Pubitemid 36374007)
21. Kehe K, Balszuweit F, Steinritz D, Tiermann H. Molecular toxicology of sulfur mustard-induced cutaneous infammation and blistering. Toxicology 2009;263:12-19.
22. PAULET G. [Cell metabolism and skin lesion caused by dichlorodiethyl sulfde (yperite); importance of glucide metabolism]. C R Seances Soc Biol Fil 1952;146:1078-1080.
23. Miccadei S, Kyle ME, Gilfor D, Farber JL. Toxic consequence of the abrupt depletion of glutathione in cultured rat hepatocytes. Arch Biochem Biophys 1988;265:311-320.
24. Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. Biochemical manipulation of intracellular glutathione levels infuences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 1993;9:259-267.
25. Atkins KB, Lodhi IJ, Hurley LL, Hinshaw DB. N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol 2000;20 Suppl 1:S125-S128.
26. Gentilhomme E, Neveux Y, Hua A, Tiriot C, Faure M, Tivolet J. Action of bis(betachloroethyl)sulphide (BCES) on human epidermis reconstituted in culture: Morphological alterations and biochemical depletion of glutathione. Toxicol In Vitro 1992;6:139-147.
27. Laskin JD, Black AT, Jan YH, Sinko PJ, Heindel ND, Sunil V et al. Oxidants and antioxidants in sulfur mustard-induced injury. Ann N Y Acad Sci 2010;1203:92-100.
28. Jin X, Ray R, Ray P. An immunochromatographic assay to detect reduced level of laminin-5 gamma2 in sulfur mustard-exposed normal human epidermal keratinocytes. J Appl Toxicol 2008;28:759-764.
29. Mishra NC, Rir-sima-ah J, March T, Weber W, Benson J, Jaramillo R et al. Sulfur mustard induces immune sensitization in hairless guinea pigs. Int Immunopharmacol 2010;10:193-199.
30. Qui M, Paromov VM, Yang H, Smith M, Stone WL. Inhibition of inducible Nitric Oxide Synthase by a mustard gas analog in murine macrophages. BMC Cell Biol 2006;7:39.
31. Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 2006;31:1-5.
32. Balali-Mood M, Hefazi M. Te pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 2005;19:297-315. (Pubitemid 40769451)
33. Constance M, Pechura DPR. (1993). Veterans at Risk: Health efects of mustard gas and lewisite. Washington, DC: National Academic Press.
34. Reid FM, Niemuth NA, Shumaker SM, Waugh JD, Graham JS. Biomechanical monitoring of cutaneous sulfur mustard-induced lesions in the weanling pig model for depth of injury. Skin Res Technol 2007;13:217-225. (Pubitemid 46443689)
35. Vijayaraghavan R, Kumar P, Dubey DK, Singh R. Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard. Biomed Environ Sci 2002;15:25-35.
36. Kumar P, Vijayaraghavan R, Kulkarni AS, Pathak U, Raza SK, Jaiswal DK. In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity. Hum Exp Toxicol 2002;21:371-376.
37. Saberi M, Zaree Mahmodabady A. Te protective efects of N-Acetl-cysteine, oxo-thiazolidine-carboxylate, acetaminophen and their combinations against sulfur mustard cytotoxicity on human skin fbroblast cell line (HF2FF). Iran Biomed J 2009;13:215-221.
38. Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol 2008;47:557-561. (Pubitemid 351676493)
39. Shohrati M, Davoudi M, Almasi M, Sadr B, Peyman M. Comparative study of Unna's Boot and betamethasone cream in the treatment of sulfur mustard-related pruritus. Cutan Ocul Toxicol 2007;26:303-309. (Pubitemid 350208871)
40. Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of clinical efcacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. Basic Clin Pharmacol Toxicol 2009;104:171-175.
41. Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J 2007;48:392-395. (Pubitemid 351235385)
42. Panahi Y, Davoudi SM, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure. Cutan Ocul Toxicol 2008;27:203-211.
43. Shohrati M, Davoudi SM, Keshavarz S, Sadr B, Tajik A. Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol 2007a;26:249-255. (Pubitemid 47237802)
44. Shohrati M, Tajik A, Harandi AA, Davoodi SM, Akmasi M. Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed 2007b;6:70-72.
45. Kadar T, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Liani H et al. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model. J Appl Toxicol 2000;20 Suppl 1:S133-S136.
46. Sawyer TW, Nelson P, Hill I, Conley JD, Blohm K, Davidson C et al. Terapeutic efects of cooling swine skin exposed to sulfur mustard. Mil Med 2002;167:939-943. (Pubitemid 35332609)
47. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS. Efcacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002;28:719-730. (Pubitemid 35425415)
48. Evison D, Brown RF, Rice PJ. Te treatment of sulphur mustard burns with laser debridement. Plast Reconstr Aesthet Surg. 2006; 59:1087-1093. (Pubitemid 44391163)
49. Anumolu SS, Menjoge AR, Deshmukh M, Gerecke D, Stein S, Laskin J, Sinko PJ. Doxycycline hydrogels with reversible disulfde crosslinks for dermal wound healing of mustard injuries. Biomaterials 2011; 32:1204-1217.
50. Arroyo CM, Kan RK, Burman DL, Kahler DW, Nelson MR, Corun CM et al. Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells. Pharmacol Toxicol 2003;92:204-213. (Pubitemid 36513216)
51. Davoudi SM, Sadr B, Hayatbakhsh MR, Keshavarz S, Shohrati M, Naghizadeh MM et al. Comparative study of skin sebum and elasticity level in patients with sulfur mustard-induced dermatitis and healthy controls. Skin Res Technol 2010;16:237-242.
52. Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a longterm investigation. Arch Dermatol 2008;144:1059-1061.
53. Case RAM, Lea AJ. Mustard gas poisoning, chronic bronchitis, and lung cancer: An investigation into the possibility that poisoning by mustard gas in the 1914-1918 war might be a factor in production of neoplasia. Br J Prev Soc Med 1955;9:62-72.
54. Norman Jr. Lung cancer mortality in World War I veterans with mustard gas injury: 1915-1965. J Natl Cancer Inst 1975;54:311-317.
55. Fletcher C, Peto R, Tinker C, Speizer F. (1976). Te natural history of chronic bronchitis and emphysema. Oxford, England: Oxford University Press.
56. Beebe G: Lung cancer in World War I veterans: possible relation to mustard gas injury and 1918 infuenza epidemic. J Nat Can Inst 1960; 25:1231-1252.
57. Wada S, Miyanishi M, Nishimoto Y, Kambe S, Miller RW. Mustard gas as a cause of respiratory neoplasia in man. Lancet 1968;1:1161-1163.
58. Emad AF, Rezaian GR, Hosseini K, Ghayyoomi SMA. Chronic pulmonary sequelae of sulfur mustard gas exposure in man. A report of 36 cases. Irn J Med Sci 1995; 20:1-4.
59. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991;127:1207-1213.
60. Sidell FR, Hurst CG. Long-term health efects of nerve agents and mustard. In: D' Alessandro MP and D' Alessandro DM, ed. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, 236-240 (Chapeter 8).
61. Pechura CM, Rall DP, eds. (1993). Veterans at risk; the health efects of mustard gas and lewisite. Washington DC: National Academy Press, 149-178, 214-226.
62. Jackson R, Adams RH. Horrifying basal cell carcinoma: a study of 33 cases and a comparison with 435 non-horror cases and a report on four metastatic cases. J Surg Oncol 1973;5:431-463.
63. Klehr NW. [Late manifestations in former mustard gas workers with special reference to cutaneous fndings]. Z Hautkr 1984;59:1161-4, 1167.
64. Mohagheghi MA, Valizadeh Y, Shariat Torbaghan SH. Development of malignant melanoma following exposure to sulfur mustard gas. Irn J Med Sci 1997; 22:155.
65. Novick M, Gard DA, Hardy SB, Spira M. Burn scar carcinoma: a review and analysis of 46 cases. J Trauma 1977;17:809-817. (Pubitemid 8207555)
66. Inada S, Hiragun K, Seo K, Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure. J Dermatol 1978;5:49-60. (Pubitemid 8353847)
67. Warren R., Heymann. Treats of biological and chemical warfare on civilian populations. J Am Acad Dermatol 2004;51:452-453.
68. Casillas RP, Kiser RC, Truxall JA, Singer AW, Shumaker SM, Niemuth NA et al. Terapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000;20 Suppl 1:S145-S151.
69. Yourick JJ, Clark CR, Mitcheltree LW. Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard. Fundam Appl Toxicol 1991;17: 533-542.
70. Newman-Taylor AJ, Morris AJ. Experience with mustard gas casualties. Lancet 1991;337:242.
71. Rice P. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol Rev 2003;22:111-118. (Pubitemid 38401301)
72. Vogt RF, Dannenberg AM, Schofeld BH, Hynes NA, Papirmeister B. Te pathogenesis of skin lesions caused by sulphur mustard. Fund Appl Toxicol 1984;4:71-83.
73. Graham JS, Stevenson RS, Mitcheltree LW, Simon M, Hamilton TA, Deckert RR et al. Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig model. J Burns Wounds 2006;5:e7.
74. Rice P, Brown RF, Lam DG, Chilcott RP, Bennett NJ. Dermabrasion-a novel concept in the surgical management of sulphur mustard injuries. Burns 2000;26:34-40.